Persistent Pseudomonas aeruginosa infection associated with non-invasive ventilation in a child with spinal muscular atrophy type 1
© 2021 American Academy of Sleep Medicine..
NONE: Current standards of care suggest the use of non-invasive positive pressure ventilation (NIV) in children with spinal muscular atrophy and symptomatic respiratory failure. Theoretical concerns exist regarding NIV equipment as a source of infection in restrictive lung disease due to the possibility of prolonged NIV device use, greater risk in acquiring infections, and difficulties in managing and clearing infections. NIV devices may draw pathogens through the air inlet port that may contaminate the internal surfaces. These pathogens may then infect children with spinal muscular atrophy. We present a case of 2 genetically identical Pseudomonas aeruginosa cultures from both the patient's NIV device and from nasopharyngeal samples. This infection persisted both in nasopharyngeal aspirate cultures and from NIV equipment cultures despite the use of an eradication program involving both the child and the NIV device.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine - 17(2021), 3 vom: 01. März, Seite 595-599 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chacko, Archana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 29.06.2021 Date Revised 02.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5664/jcsm.9014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317732560 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317732560 | ||
| 003 | DE-627 | ||
| 005 | 20231225163903.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5664/jcsm.9014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317732560 | ||
| 035 | |a (NLM)33206041 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chacko, Archana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Persistent Pseudomonas aeruginosa infection associated with non-invasive ventilation in a child with spinal muscular atrophy type 1 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2021 | ||
| 500 | |a Date Revised 02.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 American Academy of Sleep Medicine. | ||
| 520 | |a NONE: Current standards of care suggest the use of non-invasive positive pressure ventilation (NIV) in children with spinal muscular atrophy and symptomatic respiratory failure. Theoretical concerns exist regarding NIV equipment as a source of infection in restrictive lung disease due to the possibility of prolonged NIV device use, greater risk in acquiring infections, and difficulties in managing and clearing infections. NIV devices may draw pathogens through the air inlet port that may contaminate the internal surfaces. These pathogens may then infect children with spinal muscular atrophy. We present a case of 2 genetically identical Pseudomonas aeruginosa cultures from both the patient's NIV device and from nasopharyngeal samples. This infection persisted both in nasopharyngeal aspirate cultures and from NIV equipment cultures despite the use of an eradication program involving both the child and the NIV device | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a non-invasive ventilation | |
| 650 | 4 | |a pseudomonas aeruginosa | |
| 650 | 4 | |a spinal muscular atrophy type 1 | |
| 700 | 1 | |a Sly, Peter D |e verfasserin |4 aut | |
| 700 | 1 | |a Kidd, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Gauld, Leanne |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine |d 2005 |g 17(2021), 3 vom: 01. März, Seite 595-599 |w (DE-627)NLM16026278X |x 1550-9397 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:595-599 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5664/jcsm.9014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 3 |b 01 |c 03 |h 595-599 | ||